Coronary Revascularization in Patients With Diabetes: A Meta-Analysis of Randomized Controlled Trials and Propensity-Matched Studies. Issue 1 (January 2023)
- Record Type:
- Journal Article
- Title:
- Coronary Revascularization in Patients With Diabetes: A Meta-Analysis of Randomized Controlled Trials and Propensity-Matched Studies. Issue 1 (January 2023)
- Main Title:
- Coronary Revascularization in Patients With Diabetes: A Meta-Analysis of Randomized Controlled Trials and Propensity-Matched Studies
- Authors:
- Ahmed, Adham
Varghese, Kathryn S.
Fusco, Peter J.
Mathew, Dave M.
Mathew, Serena M.
Ahmed, Sarah
Rogando, Dillon O.
Salazar, Stephanie A.
Pandey, Roshan
Awad, Ahmed K.
Levy, Kenneth H.
Hernandez, Marisol
Calixte, Rose - Abstract:
- Objective: Patients with diabetes have poorer outcomes with coronary artery disease (CAD) and pose a unique clinical population for revascularization. We performed a pairwise meta-analysis of randomized trials (RCTs) and propensity-matched observational studies (PMS) to compare the clinical outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with diabetes. Methods: A comprehensive literature search was performed to identify RCT and PMS studies comparing CABG with PCI in patients with diabetes with concurrent CAD. Studies were pooled using the random-effects model to perform a pairwise meta-analysis. Primary outcomes included long-term all-cause mortality, cardiac mortality, myocardial infarction (MI), major adverse cardiac and cerebrovascular events (MACCE), and repeat revascularization. Meta-regression was used to explore the effects of baseline risk factors on primary outcomes with moderate to high heterogeneity. Results: A total of 18 RCTs and 9 PMS with 28, 846 patients were included. PCI was associated with increased long-term all-cause mortality (risk ratio [RR] = 1.34, P < 0.001), cardiac mortality (RR = 1.52, P < 0.001), MI (RR = 1.51, P = 0.009), MACCE (RR = 1.65, P < 0.001), and repeat revascularization (RR = 2.48, P < 0.001) compared with CABG. There was no difference in long-term stroke between the 2 groups (RR = 0.95, P = 0.82). At meta-regression, a greater proportion of female patients in studies wasObjective: Patients with diabetes have poorer outcomes with coronary artery disease (CAD) and pose a unique clinical population for revascularization. We performed a pairwise meta-analysis of randomized trials (RCTs) and propensity-matched observational studies (PMS) to compare the clinical outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with diabetes. Methods: A comprehensive literature search was performed to identify RCT and PMS studies comparing CABG with PCI in patients with diabetes with concurrent CAD. Studies were pooled using the random-effects model to perform a pairwise meta-analysis. Primary outcomes included long-term all-cause mortality, cardiac mortality, myocardial infarction (MI), major adverse cardiac and cerebrovascular events (MACCE), and repeat revascularization. Meta-regression was used to explore the effects of baseline risk factors on primary outcomes with moderate to high heterogeneity. Results: A total of 18 RCTs and 9 PMS with 28, 846 patients were included. PCI was associated with increased long-term all-cause mortality (risk ratio [RR] = 1.34, P < 0.001), cardiac mortality (RR = 1.52, P < 0.001), MI (RR = 1.51, P = 0.009), MACCE (RR = 1.65, P < 0.001), and repeat revascularization (RR = 2.48, P < 0.001) compared with CABG. There was no difference in long-term stroke between the 2 groups (RR = 0.95, P = 0.82). At meta-regression, a greater proportion of female patients in studies was associated with a decreased protective benefit for CABG for long-term all-cause mortality but an increased protective benefit for long-term MI and repeat revascularization. Conclusions: Revascularization of patients with diabetes using CABG is associated with significantly reduced long-term mortality, MI, MACCE, and repeat revascularizations. Future studies exploring the influence of gender on revascularization outcomes are necessary to elucidate the ideal treatment modality in patients with diabetes. Visual abstract … (more)
- Is Part Of:
- Innovations. Volume 18:Issue 1(2023)
- Journal:
- Innovations
- Issue:
- Volume 18:Issue 1(2023)
- Issue Display:
- Volume 18, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 18
- Issue:
- 1
- Issue Sort Value:
- 2023-0018-0001-0000
- Page Start:
- 29
- Page End:
- 40
- Publication Date:
- 2023-01
- Subjects:
- CABG -- PCI -- diabetes
Cardiovascular system -- Surgery -- Periodicals
Heart -- Surgery -- Periodicals
Blood-vessels -- Surgery -- Periodicals
Chest -- Surgery -- Periodicals
Thoracic Surgical Procedures -- methods -- Periodicals
Vascular Surgical Procedures -- methods -- Periodicals
Thorax -- Chirurgie -- Méthodologie -- Périodiques
Vaisseaux sanguins -- Chirurgie -- Méthodologie -- Périodiques
Blood-vessels -- Surgery
Chest -- Surgery
Periodicals
617.41 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01243895-000000000-00000 ↗
http://journals.lww.com/innovjournal/pages/default.aspx ↗
http://www.lww.com/product/?1556-9845 ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1177/15569845221143420 ↗
- Languages:
- English
- ISSNs:
- 1556-9845
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25549.xml